{"status": "Ok", "redirect_url": "https://investors.pfizer.com/Investors/news-events/News/news-details/2026/Pfizers-BRAFTOVI-Regimen-Nearly-Doubles-Median-Progression-Free-Survival-in-Metastatic-Colorectal-Cancer/default.aspx", "message": "News view counter 769190 successfully enlarged"}